CLINICAL_TRIALS
trial_result
· 2014-01-15
Clinical Trial Update: R230C and C230C Variants of ABCA1 and Glyburide Response [Phase 4]
Summary
Phase 4 clinical trial evaluating the impact of ABCA1 R230C and C230C genetic variants on glyburide response in individuals with Type 2 diabetes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED